Drugs / H6N1 Teal HK 97/AA ca vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00734175 | Sep → Dec 2008 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | H6N1 Teal HK 97/AA ca vaccine | “We evaluated the safety, infectivity, and immunogenicity of two doses of 10(7) TCID(50) of the H6N1 Teal HK 97/AA ca vaccine, a cold-adapted and temperature sensitive live,...” PMID 21377509 ↗ Mar 2011 |
| Known as | Live Influenza A Vaccine H6N1 (6-2) AA ca Recombinant | “Phase I Inpatient Study of the Safety and Immunogenicity of Live Influenza A Vaccine H6N1 (6-2) AA ca Recombinant (A/Teal/Hong Kong/W312/1997 (H6N1) x A/Ann Arbor/6/60 ca), a...” NCT00734175 ↗ |
| Modality | Vaccine | “a cold-adapted and temperature sensitive live, attenuated influenza vaccine (LAIV)” PMID 21377509 ↗ Mar 2011 |
| Route | Intranasal | “vaccine administered intranasally” NCT00734175 ↗ |